Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Toronto Stock Exchange  >  Cardiome Pharma Corp    COM   CA14159U3010

CARDIOME PHARMA CORP (COM)
Mes dernières consult.
Most popular
  Report  
SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Engages in the discovery, development and commercialization of new therapies

Cardiome Pharma Corp. is a pharmaceutical company, which engages in the provision of development and commercialization of medical products.

It focuses on cardiovascular therapies that will improve the quality of life and health of patients suffering from heart disease.

It offers the Brinavess and Aggrastat products to customers such as physicians, patients, and healthcare systems.

The company was founded on December 12, 1986 and is headquartered in Vancouver, Canada.

Sales per Businesses
20152016Delta
CAD (in Million)%CAD (in Million)%
Cardiovascular Therapies26.75100%33.46100% +25.08%
Sales per Regions
20152016Delta
CAD (in Million)%CAD (in Million)%
Europe13.5350.6%14.4843.3% +7.08%
Rest of World13.2349.4%18.9856.7% +43.5%
Managers
NameAgeSinceTitle
William L. Hunter, MD542007President, Chief Executive Officer & Director
William James O'Shea682014Chairman
Sheila M. Grant, MBA-2003Chief Operating Officer
Justin A. Renz MBA, CPA462017Chief Financial Officer
Richard M. Glickman, PhD712006Lead Independent Director
Mark H. N. Corrigan, MD612015Director
Arthur H. Willms782015Independent Director
Robert James Meyer, MD-2015Director
Jennifer Archibald-2006Chief Business Operations Officer
Steen Juul-Möller MD, PhD-2013Medical Director-Europe
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 34,628,842 33,775,618 97.5% 0 0.0% 97.5%
Shareholders
NameEquities%
Westfield Capital Management Co. LP 4,758,844 14.9%
Putnam Investment Management LLC 3,706,324 11.6%
Stonepine Capital Management LLC 3,158,816 9.91%
Clough Capital Partners LP 2,878,985 9.03%
Tamarack Advisers LP 1,825,000 5.73%
Rock Springs Capital Management LP 1,200,000 3.76%
William L. Hunter, MD 814,304 2.55%
AlphaOne Investment Services LLC 600,625 1.88%
Renaissance Technologies LLC 411,413 1.29%
JPMorgan Securities LLC (Investment Management) 158,697 0.50%
Company contact information
Cardiome Pharma Corp.
1441 Creekside Drive
6th floor
Vancouver, BC V6J 4S7

Phone : +1.604.677.6905
Fax : +1.604.677.6915
Web : www.cardiome.com
Sector Biopharmaceuticals
Connections : Cardiome Pharma Corp
Zalicus Pharmaceuticals Ltd.
Kyowa Kirin International Plc
Advanced Applied Physics Solutions, Inc.
Nabriva Therapeutics AG
Trevi Therapeutics, Inc.
The Vancouver Symphony Foundation
Premier's Technology Council
Virginia Center For Translational & Regulatory Sciences
Quartet Medicine, Inc.
Brighton Biotech, Inc.
Michael Smith Foundation for Health Research
Richardson Capital Ltd.
Synereca Pharmaceuticals, Inc.
enGene, Inc.
Pamlico BioPharma, Inc.
MedGenesis Therapeutix, Inc.
Vancouver Symphony Orchestra
Vida Pharmaceuticals Pvt Ltd.
British Columbia Lottery Corp.
Kearny Venture Partners
The 2010 Games Operating Trust
Lumira Capital Investment Management, Inc.
Pacific Autism Family Centre Foundation
Blackthorn Therapeutics, Inc.
Correvio International SARL
© 2018 People , Fundamentals and Ownership